CLINICAL_TRIALS
ClinicalTrials.gov record update
Neoadjuvant Toripalimab Combined With Chemotherapy in Rare Mutations Stage IIB-IIIB NSCLC
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT05800340
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:39:14.381661+00:00
- Published At
- 2023-04-05T00:00:00+00:00
- Record Updated At
- 2023-04-05
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Non-Small Cell Lung Cancer", "RET Driver Mutation", "BRAF V600 Mutation", "Erb-B2 Receptor Tyrosine Kinase Exon 20 Mutation", "MET Amplification", "MET Exon 14 Skipping Mutation"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-04-05"- protocolSection.identificationModule.nctId
"NCT05800340"- protocolSection.identificationModule.officialTitle
"Neoadjuvant Toripalimab Combined With Chemotherapy in Rare Mutations Stage IIB-IIIB NSCLC"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.